Back to Menu
Acoustic neuroma is a benign tumor arising from the Schwann cell sheath of the vestibulocochlear nerve. Although it does not metastasize, its mass effect can compress the cochlear nerve, facial nerve, and brainstem, resulting in severe functional impairment such as hearing loss.
1. Classification by occurrence and hereditary background
Unilateral sporadic tumors account for approximately 95% and are nonhereditary; NF2-associated bilateral tumors account for about 5%, are hereditary, and present at a younger age.
2. Clinical grading by tumor size
Grade 1 is confined to the internal auditory canal; grades 2–3 extend into the cerebellopontine angle; grade 4 represents giant tumors compressing the brainstem.
3. Histopathological classification
Tumors are classified as Antoni A (hypercellular) and Antoni B (hypocellular) patterns. Imaging phenotypes include solid and cystic lesions.
1. Gene mutations (core cause)
Sporadic acoustic neuromas are associated with inactivating mutations of the NF2 gene on chromosome 22, resulting in loss of function of the merlin protein.
2. Genetic factors
Neurofibromatosis type 2 is a hereditary cause; germline NF2 mutations often lead to bilateral acoustic neuromas.
3. Environmental and potential risk factors
Long-term exposure to high-intensity noise, ionizing radiation, and unhealthy lifestyle factors may increase risk, although evidence is limited.
1. Pay attention to unilateral hearing abnormalities
Be highly vigilant for unilateral hearing loss or tinnitus and undergo audiologic evaluation and internal auditory canal MRI screening promptly.
2. Genetic counseling and family screening
Bilateral cases and first-degree relatives should undergo NF2 genetic testing and counseling for risk assessment.
3. Lifelong follow-up after treatment
Regardless of treatment modality, long-term cranial MRI surveillance and assessment of hearing and facial nerve function are required to monitor recurrence.
4. Functional rehabilitation and lifestyle adaptation
Postoperative vestibular rehabilitation can improve dizziness. Individuals with unilateral deafness should adopt safety precautions (e.g., traffic safety) and other adaptations.
5. Healthy lifestyle and complication management
Avoid high-intensity noise exposure, manage dry eye and psychological issues, and seek help when needed.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although acoustic neuroma is benign, it can cause deafness, facial palsy, and intracranial hypertension. Accurate diagnosis and standardized treatment are essential. Modern minimally invasive approaches combined with MDT-based multidisciplinary collaboration support individualized selection among observation, radiotherapy, and surgery to control the tumor and preserve neurological function.
Acoustic neuroma is a benign tumor arising from the Schwann cell sheath of the vestibulocochlear nerve. Although it does not metastasize, its mass effect can compress the cochlear nerve, facial nerve, and brainstem, resulting in severe functional impairment such as hearing loss.
1. Classification by occurrence and hereditary background
Unilateral sporadic tumors account for approximately 95% and are nonhereditary; NF2-associated bilateral tumors account for about 5%, are hereditary, and present at a younger age.
2. Clinical grading by tumor size
Grade 1 is confined to the internal auditory canal; grades 2–3 extend into the cerebellopontine angle; grade 4 represents giant tumors compressing the brainstem.
3. Histopathological classification
Tumors are classified as Antoni A (hypercellular) and Antoni B (hypocellular) patterns. Imaging phenotypes include solid and cystic lesions.
1. Gene mutations (core cause)
Sporadic acoustic neuromas are associated with inactivating mutations of the NF2 gene on chromosome 22, resulting in loss of function of the merlin protein.
2. Genetic factors
Neurofibromatosis type 2 is a hereditary cause; germline NF2 mutations often lead to bilateral acoustic neuromas.
3. Environmental and potential risk factors
Long-term exposure to high-intensity noise, ionizing radiation, and unhealthy lifestyle factors may increase risk, although evidence is limited.
1. Pay attention to unilateral hearing abnormalities
Be highly vigilant for unilateral hearing loss or tinnitus and undergo audiologic evaluation and internal auditory canal MRI screening promptly.
2. Genetic counseling and family screening
Bilateral cases and first-degree relatives should undergo NF2 genetic testing and counseling for risk assessment.
3. Lifelong follow-up after treatment
Regardless of treatment modality, long-term cranial MRI surveillance and assessment of hearing and facial nerve function are required to monitor recurrence.
4. Functional rehabilitation and lifestyle adaptation
Postoperative vestibular rehabilitation can improve dizziness. Individuals with unilateral deafness should adopt safety precautions (e.g., traffic safety) and other adaptations.
5. Healthy lifestyle and complication management
Avoid high-intensity noise exposure, manage dry eye and psychological issues, and seek help when needed.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although acoustic neuroma is benign, it can cause deafness, facial palsy, and intracranial hypertension. Accurate diagnosis and standardized treatment are essential. Modern minimally invasive approaches combined with MDT-based multidisciplinary collaboration support individualized selection among observation, radiotherapy, and surgery to control the tumor and preserve neurological function.